Found runs an asynchronous model: an online assessment, a clinician review that its site describes as taking one to two days, a prescription if eligible, then monthly check-ins and refills timed to the billing cycle. The prescribing is done by contracted medical groups rather than by Found itself, and that structural detail explains most of the confusion members report.
Understanding the handoffs is what separates a solvable delay from a reason to leave. Every stall in this model happens at a boundary between two organizations.
Who actually writes the prescription
Found’s terms state plainly that Found does not provide medical services. The company contracts with named professional entities, including Pippen Health and Cloud Health Medical Group practices in several states, along with other affiliated groups, and the clinician relationship is with those groups rather than with Found. Pharmacies and laboratories are described as independent third parties as well.
This is the standard corporate structure for telehealth in the United States, and it is not hidden. It does mean a member is dealing with at least three organizations: the platform that bills them, the medical group whose clinician prescribes, and the pharmacy that dispenses. A question about a dose belongs to the second. A question about a shipment belongs to the third. Sending either to the first adds a hop.
The path from assessment to first shipment
Found’s program page describes a four-step sequence: an assessment of roughly ten to fifteen minutes, clinician review within one to two days, a personalized medication plan with shipping if eligible, and monthly ongoing care with adjustments. The site says most members can begin treatment within about a week of completing the assessment.
Eligibility is decided at step two, and it is the step where expectations most often break. Found’s refund policy distinguishes between being disqualified from all treatment options, which it says qualifies for a full membership refund, and being disqualified from one particular medication while remaining eligible for others, which it says does not. Someone who signed up specifically wanting one drug and was offered a different pathway is in the second bucket.
How refills are actually timed
Refills in this model are tied to the billing cycle rather than to a pharmacy counter. Found’s offer terms describe plan pricing billed every four weeks on a 28-day cycle, so the supply rhythm follows that cadence. Injectable GLP-1 treatment is weekly, which makes a 28-day cycle a clean four doses, but it also means the renewal date walks backward through the calendar over a year.
| Stage | Who owns it | Typical stall | What resolves it fastest |
|---|---|---|---|
| Intake assessment | The member | Incomplete health history | Answer fully the first time |
| Clinician review | Contracted medical group | Follow-up questions awaiting a reply | Check secure messages daily |
| Prescription transmission | Medical group to pharmacy | State or eligibility restriction | Confirm state availability early |
| Dispensing | Third-party pharmacy | Compounding batch schedule | Ask for the fill date, not the ship date |
| Delivery | Carrier | Weather holds on cold-chain parcels | Request tracking at dispatch |
| Refill authorization | Medical group | Missed monthly check-in | Complete check-ins before the cycle ends |
The check-in requirement is the one members underestimate. Ongoing prescribing in these programs is conditional on periodic clinical contact, so a skipped check-in can hold a refill even when payment is current. That produces a complaint that reads as a supply failure but originates in the intake queue.
What support covers, and what it cannot
Found describes on-demand support availability alongside an in-app assistant it calls Aimee, plus monthly provider check-ins and a member community. Two different queues exist behind that: clinical messaging handled by the medical group, and billing and account questions handled by the platform. They move at different speeds, and a clinical question sent to the billing queue waits twice.
Research on direct-to-consumer telemedicine has consistently found that access and convenience are the model’s strengths while continuity and coordination are where quality varies. That is the honest frame for support at any asynchronous provider: fast to reach, slower to resolve anything requiring two organizations to agree.
Continuity is the thing worth protecting
Real-world data on GLP-1 treatment shows that a large share of people stop within the first year, and reviews of adherence and persistence point to cost, side effects during escalation, and supply interruptions as the recurring drivers rather than lack of motivation. Discontinuation is also clinically consequential, since trial extension data show weight regain after withdrawal.
That makes the operational questions medical ones. Before starting, it is worth confirming what happens if a shipment is late, whether the plan pauses billing during a supply gap, and how a dose change is requested between check-ins. Cash-pay programs differ in how much of that they commit to in writing, and FormBlends is one of the physician-supervised providers that sets out its supervision model and pricing before an account is created rather than after.
Compounded medication is not FDA-approved, so the agency has not reviewed those preparations for safety, effectiveness, or manufacturing quality. Pharmacy practice groups have published guidance on the extra monitoring compounded incretin products call for, and that oversight burden falls on the prescribing relationship, which is exactly why the handoff structure above matters.
The way to test any of this is to line up a few named programs on the same questions. Ro and Hims and Hers run large multi-service telehealth operations, Henry Meds built around cash-pay compounded access, and HealthRX is among the providers that describe their GLP-1 medication options and refill process openly rather than only after intake. A member who compares two or three on late-shipment handling and refill timing learns more than any single review thread offers.
Frequently asked questions
Why does a refill need a check-in when the prescription already exists?
Ongoing prescribing is conditional on periodic clinical contact rather than being a standing authorization. The clinician is reassessing tolerance, response, and whether the strength should change. Missing that contact stops the authorization at the medical group, which looks identical from the outside to a pharmacy delay but is resolved differently.
Who should be contacted about a late shipment?
Start with the platform’s support channel, because it can see the fulfillment record, then ask specifically for the fill date and the carrier tracking number. Those two facts distinguish a compounding queue backlog from a delivery problem, and the two have completely different resolutions and timelines.
What happens to treatment if the subscription is canceled?
Found’s terms state that access to providers and prescription medication is suspended as of the cancellation date. Because dose escalation is scheduled, an abrupt stop mid-titration creates a gap that a new provider will usually need to work around. Sequencing a switch around the current supply avoids restarting the escalation.
Does an asynchronous model mean never speaking to a clinician?
Not necessarily, though most contact in this model is written. Secure messaging with the medical group is the primary channel, with periodic structured check-ins. Anyone who wants scheduled synchronous appointments should confirm that they are available before enrolling, since programs vary widely on this point.
